Clinical Efficacy of Etanercept Versus Sulfasalazine in Ankylosing Spondylitis Subjects with Peripheral Joint Involvement
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F13%3A%230002011" target="_blank" >RIV/00023728:_____/13:#0002011 - isvavai.cz</a>
Result on the web
<a href="http://www.jrheum.org/content/39/4/836" target="_blank" >http://www.jrheum.org/content/39/4/836</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3899/jrheum.110885" target="_blank" >10.3899/jrheum.110885</a>
Alternative languages
Result language
angličtina
Original language name
Clinical Efficacy of Etanercept Versus Sulfasalazine in Ankylosing Spondylitis Subjects with Peripheral Joint Involvement
Original language description
Randomised, controlled trial of anti TNF drug etanercept vs. sulfasalazin in patients with ankylosing spondylitis and swelling of at least 1 peripheral joint. Study has shown that anti TNF therapy is more effective based on this study it is not necessaryto treated patients with SAS before initiation of anti TNF therapy.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
JOURNAL OF RHEUMATOLOGY
ISSN
0315-162X
e-ISSN
—
Volume of the periodical
39
Issue of the periodical within the volume
4
Country of publishing house
CA - CANADA
Number of pages
5
Pages from-to
836-840
UT code for WoS article
000302840800028
EID of the result in the Scopus database
—